Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
May 13 2026 - 8:00AM


Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel the tumor microenvironment (“TME”), and enable high-level expression of therapeutic genetic payloads directly within tumors.
Dr. Santidrian will discuss the engineering of the RedTail platform and present new data on CLD-401, the first lead from the RedTail platform. CLD-401 is a systemically delivered virotherapy designed to selectively target tumors and enable high-level expression of IL-15 superagonist (“IL-15 SA”), a known T- and NK-cell activator, driving profound immune changes in the TME, including the recruitment and activation of NK, NK-T, and gamma delta (?d) T-cells that lead to a robust therapeutic response in immunocompetent animal models. The Company expects to file an IND for CLD-401 by the end of 2026. In addition to IL-15 SA delivery with CLD-401, the RedTail platform has also been shown to enable in situ expression of tumor-targeted T cell engagers, as demonstrated in a separate American Association for Cancer Research (AACR) presentation focused on the CLD-501 program.

“The data I will discuss tomorrow demonstrates the potential of the RedTail platform as systemic virotherapy that can deliver genetic medicine to metastatic sites after systemic administration,” said Dr. Santidrian. “The ability of CLD-401 to induce high levels of IL15-SA expression in the TME while maintaining low circulating levels may dramatically expand the therapeutic window of IL-15-mediated treatment.”

The Company continues to expand the functionality of the RedTail platform, with data presented at AACR across multiple programs including CLD-401 and CLD-501, and is also actively pursuing strategic partnerships to accelerate clinical development and broaden the impact of its RedTail platform.

CLDI.....................................p/m

$CLDI Come on $GME we have only 10.9 million shares, you guys have 448 million shares. That's like about 10x as many shares. You're chasing lightning to fill a bottle for the 3rd time. $AMC you have 529 million shares. Both of your company's boards will just dilute into any run,

barreled bacK end of daY… 🤓

CLDI....................................https://stockcharts.com/sc3/ui/?s=CLDI&p=w&b=5&g=0&id=p86431144783

News and gains on the news - I was wondering if this would ever wake up.

Any updates?

It is a disaster I. see what happens tomorrow

CLDI HERE WE GO...BIO POST RS BEAST

CLDI...PICKING UP STEAM

CLDI SLOW AND STEADY

YES

CLDI post RS it’s been beat down since split

$CLDI: What happened here.......... now $5.75 ?????

Chart shows it was $85 last week.

What am I missing here ??


GO $CLDI

Fast track .92 + 68%

Looks good for tomorrow t

CLDI...........................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

$CLDI: Wow....... whatta Runner here today, hit $1.55

Biggggggggggg bump and continuation from yesterday at $0.30

Well done.


GO $CLDI

cldi..............................................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI...................................................................................................................a/h

meeting coming up july 9th...subjects to talk about are reelection of officers...another thing on the agenda is to discuss and possibly vote for a reverse stock split anywhere from 1 to 2 as far as 1 to 19 reverse stock split...read this on the seeking alpha site....

CLDI promotion on Bloomberg by some group called RedChip . . . I think that was their name. 

Are we in for another run up soon?

CLDI......................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

cldi........................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI under $2

CLDI........................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

Let's ride this to $1.00++ soon. CLDI .78 cents now. Chart Looks primed here with CLDI Calidi Biotherapeutics Ends SEPA After Successful Fundraising

Story Highlights
Calidi Biotherapeutics terminated its SEPA with Yorkville effective January 23, 2025.
The company raised $9.6 million by December 31, 2024, enhancing its cash position and focus on clinical goals.

CLDI........................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

Hi Glen in here with you at .73 cents


CLDI.........................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI, under $2

CLDI.........................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI......................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

$3.50 + 70% Pump time next resistance at $3.80 if it got crazy next level in $5s 

CLDI....................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI.........................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

CLDI.............................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783

Go again lol $1.17 back to .99
Or ready to pump 

Yep, golden opportunity!

LOL, well no one is selling and the stock showed good gains end of week. Very bullish!

They were not BUYS but option awards not one of them have exercised their right to buy at $1.09.

It is not bullish at all

CLDI under $2

Fantastic buying opportunity. 6 company officers filed Form 4's last week, all buys. Bullish

CLDI new 52 week low

CLDI under $2

CLDI new 52=week low

CLDI..NEXT POST SPLIT BUCKAROO!!!!

CLDI under $2

CLDI under $2

Probably because it is a worthless company that is heavily in debt and by all rights it should be kicked off the Nasdaq but Nasdaq urges these worthless companies to screw their shareholders to artificially get their stock price to $1 - I expect a landslide decline back to a quarter in short order.

This is one of my bets that doesn't look like it will make me any money - unless they can somehow pump it up on the fact the the OS will be about 5 million shares on split day.

Just my take on it after looking thru Q1 Quarterly report.